GlassScriptPhysician profile
Andre E Ghantous
NPI 1790731354
$11,874.55
in general payments reported to CMS, 2019-2025
39 companies · $2,449 in 2025
The $2,449 reported for 2025 was more than what 86% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,693 · 2020: $119 · 2021: $214 · 2022: $3,498 · 2023: $2,066 · 2024: $1,836 · 2025: $2,449.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,408 · Travel and Lodging: $943.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,407.80 |
| Travel and Lodging | $943.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,336.48 | 2019-2025 | Cardiomems |
| Boston Scientific Corporation | $1,750.08 | 2022-2025 | Watchman Flx, Watchman Access System, Watchman |
| Novartis Pharmaceuticals Corporation | $1,035.00 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $548.22 | 2021-2025 | Verquvo, Capvaxive |
| Novo Nordisk INC | $397.14 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Heartflow, INC. | $382.44 | 2022-2025 | Ffrct |
| Impulse Dynamics (USA) INC. | $378.42 | 2022-2024 | Optimizer, Optimizer |
| Astrazeneca Pharmaceuticals LP | $373.07 | 2019-2025 | Farxiga, Wainua |
| Amgen INC. | $364.78 | 2019-2025 | Repatha, Repatha |
| Janssen Pharmaceuticals, INC | $355.76 | 2019-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $333.23 | 2019-2025 | Jardiance |
| Pfizer INC. | $330.98 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $287.80 | 2019-2024 | Eliquis, Camzyos |
| Medtronic, INC. | $282.17 | 2022-2024 | Harmony, Azure Xt Dr Mri Surescan |
| Philips North America LLC | $231.55 | 2022-2023 |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ge Healthcare | $230.75 | 2019-2023 | |
| Scpharmaceuticals INC. | $153.55 | 2023-2025 | |
| Kiniksa Pharmaceuticals International, Plc | $123.07 | 2024 | Arcalyst |
| Alnylam Pharmaceuticals INC. | $108.79 | 2024-2025 | Amvuttra, Onpattro |
| Lexicon Pharmaceuticals, INC. | $100.06 | 2023-2024 | Inpefa |
| Abiomed | $85.21 | 2024-2025 | Impella |
| Lilly USA, LLC | $80.16 | 2025 | Zepbound, Mounjaro |
| Baxter Healthcare | $78.29 | 2023-2024 | Hillrom - Cardiac Ambulatory Monitor, Hillrom - Carnation Ambulatory Monitor |
| Regeneron Healthcare Solutions, INC. | $77.98 | 2019-2025 | Evkeeza |
| Bayer Healthcare Pharmaceuticals INC. | $63.88 | 2025 | |
| Kiniksa Pharmaceuticals, LTD. | $59.35 | 2023 | Arcalyst |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $55.61 | 2019-2025 | Lifevest |
| Medtronic Vascular, INC. | $41.12 | 2019 | |
| Amarin Pharma, INC. | $33.53 | 2019 | |
| Shockwave Medical, INC | $26.94 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Lantheus Medical Imaging, INC. | $26.02 | 2022 | |
| Penumbra, INC. | $23.03 | 2025 | Indigo System |
| Opsens INC. | $20.10 | 2022 | |
| Preventice Services, LLC | $20.01 | 2019 | |
| Portola Pharmaceuticals, LLC | $18.34 | 2019 | |
| Sirtex Medical INC | $17.81 | 2024 | Lava Les (Liquid Embolic System) |
| Sanofi-Aventis U.S. LLC | $15.06 | 2020 | |
| Siemens Medical Solutions USA, INC. | $14.87 | 2023 | Acuson Sequoia Diagnostic Ultrasound System |
| Chiesi USA, INC. | $13.90 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andre Ghantous listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.